Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients
- Conditions
- Fabry Disease
- Interventions
- Genetic: GLA gene
- Registration Number
- NCT03596398
- Lead Sponsor
- Chiayi Christian Hospital
- Brief Summary
Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients
- Detailed Description
This is a cross-sectional, population-based study. No randomization procedure will be executed in this study. Approximately 1000 subjects over a 36-month period. The aim of this screening study is to identify the Fabry disease as the cause in patients with young stroke.
To measure the level of α-Gal A activity, male subjects will initially provide a DBS sample and female subjects will start with a test by whole blood sample.
The prevalence of Fabry disease among patients with young stroke will be estimated by a confirmative diagnosis in gene testing.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1000
- Patients aged 20 or over
- Patients aged under 56 years old, not included 56
- Patients with acute stroke
- Patients and/or their legal representatives are willing to provide written informed consent
- Patients with a confirmed diagnosis of Fabry disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Young stroke GLA gene Patients with acute stroke aged 20 or over, and under 56 years old (Not included 56) .
- Primary Outcome Measures
Name Time Method Fabry disease 3 years later The prevalence of Fabry disease in patients with young stroke
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.